Outcome Measures in Rheumatology

Outcome Measures in Rheumatology

OMERACT logo

Outcome Measures in Rheumatology (OMERACT) is an international initiative focused on improving outcome measurement in rheumatology. It aims to enhance the quality and consistency of clinical trials and observational studies in rheumatology by developing and validating standardized outcome measures.

History

OMERACT was established in 1992 as a response to the need for standardized outcome measures in rheumatology research. The initiative began with a conference held in Maastricht, Netherlands, where experts in the field gathered to discuss and develop consensus on outcome measures.

OMERACT 1992 conference

Since its inception, OMERACT has grown into a global network of researchers, clinicians, and patients who collaborate to identify and validate core outcome sets for various rheumatologic conditions.

Objectives

The primary objectives of OMERACT are:

• To develop and validate core outcome sets for rheumatologic conditions.
• To ensure that these outcome measures are relevant to patients, clinicians, and researchers.
• To promote the use of these standardized measures in clinical trials and observational studies.

Methodology

OMERACT employs a rigorous methodology to develop outcome measures. This includes:

• Literature Review: Comprehensive reviews of existing literature to identify potential outcome measures.
• Delphi Process: A structured communication technique that involves multiple rounds of surveys to reach consensus among experts.
• Workshops and Conferences: Regular meetings where stakeholders discuss and refine outcome measures.
• Validation Studies: Empirical studies to test the reliability and validity of proposed measures.

Core Outcome Sets

OMERACT has developed core outcome sets for a variety of rheumatologic conditions, including:

• Rheumatoid arthritis
• Osteoarthritis
• Ankylosing spondylitis
• Systemic lupus erythematosus

These core sets typically include domains such as pain, physical function, and patient global assessment.

Impact

OMERACT has significantly influenced the field of rheumatology by:

• Standardizing outcome measures, which facilitates comparison across studies.
• Enhancing the quality of evidence available for clinical decision-making.
• Increasing the involvement of patients in the research process, ensuring that outcomes are meaningful to them.

Related Pages

• Rheumatology
• Clinical trial
• Patient-reported outcome
• Evidence-based medicine